XOMA Royalty to acquire Generation Bio for potential milestone and royalty payments in collaboration with Moderna.
XOMA Royalty has gained the opportunity to receive milestone payments and royalties through its acquisition, under Generation Bio's collaboration with Moderna.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments